Jehovah's Witnesses and cardiac surgery: A single institution's experience

Transfusion

Volumn 54, Issue 1, 2014, Pages 2745-2752

  McCartney, Sharon ^a   Guinn, Nicole ^a   Roberson, Russell ^b   Broomer, Bob ^a   White, William ^a   Hill, Steven ^b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; ANTIFIBRINOLYTIC AGENT; APROTININ; DESMOPRESSIN; ERYTHROPOIETIN; FERROUS GLUCONATE; FERROUS SULFATE; HEMOGLOBIN; IRON; IRON DEXTRAN; IRON SACCHARATE;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD TRANSFUSION; BLOODLESS CARE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; FEMALE; HEART SURGERY; HEMODILUTION; HEMOGLOBIN DETERMINATION; HUMAN; INFARCTION; JEHOVAH'S WITNESS; LENGTH OF STAY; MALE; MEDICAL RECORD REVIEW; MORTALITY; OFF PUMP CORONARY SURGERY; PEROPERATIVE CARE; POSTOPERATIVE CARE; PREOPERATIVE CARE; RELIGIOUS GROUP; TREATMENT OUTCOME; VERY ELDERLY; BIOLOGICAL MODEL; BODY WEIGHT; MIDDLE AGED; PERIOPERATIVE PERIOD; PROCEDURES; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; UNIVERSITY HOSPITAL; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BLOOD TRANSFUSION; BLOODLESS MEDICAL AND SURGICAL PROCEDURES; BODY WEIGHT; CARDIAC SURGICAL PROCEDURES; FEMALE; HEMOGLOBINS; HOSPITAL MORTALITY; HOSPITALS, UNIVERSITY; HUMANS; JEHOVAH'S WITNESSES; LENGTH OF STAY; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PERIOPERATIVE CARE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84908384420     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12696     Document Type: Article

References (26)

1. International Bible Society. The holy bible: new international version. Vol Acts 15:28-29. Colorado Springs, CO: International Bible Society; 1984.
2. International Bible Society. The holy bible: new international version. Vol Leviticus 17:14. Colorado Springs, CO: International Bible Society; 1984.
3. Watch Tower Bible and Tract Society CBWB, Tract Society of New York. Questions from readers. The Watchtower. Brooklyn, N.Y.; Toronto: Watch Tower Bible and Tract Society of Pennsylvania; Watch Tower Bible and Tract Society. 2004: 29-31.
4. Watch Tower Bible and Tract Society CBWB, Tract Society of New York. Questions from readers. The Watchtower. Brooklyn, N.Y.; Toronto: Watch Tower Bible and Tract Society of Pennsylvania; Watch Tower Bible and Tract Society. 2000: 30-31.
5. Vaislic CD, Dalibon N, Ponzio O, et al. Outcomes in cardiac surgery in 500 consecutive Jehovah's Witness patients: 21 year experience. J Cardiothorac Surg 2012; 7: 95.
6. Pattakos G, Koch CG, Brizzio ME, et al. Outcome of patients who refuse transfusion after cardiac surgery: a natural experiment with severe blood conservation. Arch Intern Med 2012; 172: 1154-1160.
7. Moraca RJ, Wanamaker KM, Bailey SH, et al. Strategies and outcomes of cardiac surgery in Jehovah's Witnesses. J Card Surg 2011; 26: 135-143.
8. Shaw RE, Johnson CK, Ferrari G, et al. Blood transfusion in cardiac surgery does increase the risk of 5-year mortality: results from a contemporary series of 1714 propensity-matched patients. Transfusion 2014; 54: 1106-1113.
9. Bhaskar B, Dulhunty J, Mullany DV, et al. Impact of blood product transfusion on short and long-term survival after cardiac surgery: more evidence. Ann Thorac Surg 2012; 94: 460-467.
10. LaPar DJ, Crosby IK, Ailawadi G, et al. Blood product conservation is associated with improved outcomes and reduced costs after cardiac surgery. J Thorac Cardiovasc Surg 2013; 145: 796-803; discussion 803-794.
11. Galas FR, Almeida JP, Fukushima JT, et al. Blood transfusion in cardiac surgery is a risk factor for increased hospital length of stay in adult patients. J Cardiothorac Surg 2013; 8: 54.
12. Swaminathan M, Phillips-Bute BG, Conlon PJ, et al. The association of lowest hematocrit during cardiopulmonary bypass with acute renal injury after coronary artery bypass surgery. Ann Thorac Surg 2003; 76: 784-791.
13. Society of Thoracic Surgeons Blood Conservation Guideline Task Force, Ferraris VA, Brown JR, Despotis GJ, et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg 2011; 91: 944-982.
14. Alghamdi AA, Albanna MJ, Guru V, et al. Does the use of erythropoietin reduce the risk of exposure to allogeneic blood transfusion in cardiac surgery? A systematic review and meta-analysis. J Card Surg 2006; 21: 320-326.
15. Weltert L, D'Alessandro S, Nardella S, et al. Preoperative very short-term, high-dose erythropoietin administration diminishes blood transfusion rate in off-pump coronary artery bypass: a randomized blind controlled study. J Thorac Cardiovasc Surg 2010; 139: 621-626. discussion 626-627.
16. D'Ambra MN, Gray RJ, Hillman R, et al. Effect of recombinant human erythropoietin on transfusion risk in coronary bypass patients. Ann Thorac Surg 1997; 64: 1686-1693.
17. Taketani T, Motomura N, Toyokawa S, et al. Beneficial effect of acute normovolemic hemodilution in cardiovascular surgery. Jpn J Thorac Cardiovasc Surg 2005; 53: 16-21.
18. Casati V, Benussi S, Sandrelli L, et al. Intraoperative moderate acute normovolemic hemodilution associated with a comprehensive blood-sparing protocol in off-pump coronary surgery. Anesth Analg 2004; 98: 1217-1223; table of contents.
19. Karkouti K, Wijeysundera DN, Yau TM, et al. The influence of baseline hemoglobin concentration on tolerance of anemia in cardiac surgery. Transfusion 2008; 48: 666-672.
20. Brown JR, Birkmeyer NJ, O'Connor GT,. Meta-analysis comparing the effectiveness and adverse outcomes of antifibrinolytic agents in cardiac surgery. Circulation 2007; 115: 2801-2813.
21. Cattaneo M, Harris AS, Stromberg U, et al. The effect of desmopressin on reducing blood loss in cardiac surgery-a meta-analysis of double-blind, placebo-controlled trials. Thromb Haemost 1995; 74: 1064-1070.
22. Zeigler ZR, Megaludis A, Fraley DS,. Desmopressin (d-DAVP) effects on platelet rheology and von Willebrand factor activities in uremia. Am J Hematol 1992; 39: 90-95.
23. Steinlechner B, Zeidler P, Base E, et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion. Ann Thorac Surg 2011; 91: 1420-1426.
24. Wang G, Bainbridge D, Martin J, et al. The efficacy of an intraoperative cell saver during cardiac surgery: a meta-analysis of randomized trials. Anesth Analg 2009; 109: 320-330.
25. Sun P, Ji B, Sun Y, et al. Effects of retrograde autologous priming on blood transfusion and clinical outcomes in adults: a meta-analysis. Perfusion 2013; 28: 238-243.
26. Wahba A, Rothe G, Lodes H, et al. The influence of the duration of cardiopulmonary bypass on coagulation, fibrinolysis and platelet function. Thorac Cardiovasc Surg 2001; 49: 153-156.